ARTEMIS MED SERVICE LTD (ARTEMISMED) financials

ARTEMIS MED SERVICE LTD (ARTEMISMED) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Artemis Medicare Services Ltd (AMSL) was incorporated in 2004, operates a 541-bedded multi-specialty tertiary care hospital in Gurgaon.[1][2]

Market Cap: ₹4,850Cr.
Current Price: ₹306
Stock P/E: 42.0
ROE: 11.9%
ROCE: 14.5%
Book Value: ₹59.3
Dividend Yield: 0.15%
52W High / Low: ₹379/203

In Jun 2026, ARTEMIS MED SERVICE LTD (ARTEMISMED) reported sales ₹282 Cr and net profit ₹31 Cr.

Annual TTM: sales ₹1,093 Cr, net profit ₹113 Cr.

Shareholding: Promoters 58.39% (Sep 2026), FIIs 12.45% (Sep 2026), DIIs 1.91% (Sep 2026), Government 6.16% (Sep 2026), Public 21.07% (Sep 2026).

ARTEMISMED quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	235	227	235	250	270	267	274	282
Expenses	193	190	199	209	220	223	224	227
Operating Profit	42	37	36	41	50	44	50	55
OPM %	18%	16%	15%	16%	19%	16%	18%	20%
Other Income	8	9	12	7	8	4	8	5
Interest	8	8	8	7	7	7	6	6
Depreciation	11	11	11	11	11	12	12	12
Profit before tax	31	27	29	30	40	30	39	42
Tax %	27%	23%	20%	29%	25%	24%	25%	26%
Net Profit	23	21	23	21	30	23	30	31
EPS in Rs	1.64	1.51	1.69	1.54	2.16	1.42	1.87	1.96
Raw PDF	—	—	—	—	—	—	—	—

ARTEMISMED profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	563	402	545	714	845	913	1,060	1,093
Expenses	501	367	477	620	717	763	875	893
Operating Profit	62	35	68	94	128	150	185	200
OPM %	11%	9%	12%	13%	15%	16%	17%	18%
Other Income	4	7	3	7	7	33	27	25
Interest	13	12	11	19	30	30	27	26
Depreciation	22	21	21	29	38	43	46	48
Profit before tax	32	9	39	53	68	109	139	151
Tax %	36%	20%	16%	25%	28%	24%	25%	—
Net Profit	20	7	33	40	49	83	103	113
EPS in Rs	1.54	0.54	2.46	2.96	3.62	6.07	6.53	7.41
Dividend Payout %	0%	0%	0%	15%	12%	7%	7%	—

ARTEMISMED balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	0.00	13	13	13	13	14	14	16
Reserves	280	301	308	348	393	438	828	923
Borrowings	114	108	137	190	268	305	280	260
Other Liabilities	160	159	130	145	207	191	221	225
Total Liabilities	555	581	589	697	882	948	1,343	1,424
Fixed Assets	381	387	372	476	584	699	729	790
CWIP	49	56	81	64	95	33	40	33
Investments	0	2	4	6	12	15	15	15
Other Assets	124	137	132	152	192	200	559	585
Total Assets	555	581	589	697	882	948	1,343	1,424

ARTEMISMED cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	41	56	27	61	129	108	150	129
Cash from Investing Activity	-50	-22	-34	-106	-153	-90	-396	-96
Cash from Financing Activity	14	-33	12	44	30	-26	274	-41
Net Cash Flow	5	2	6	-2	7	-8	28	-8
Free Cash Flow	-17	37	2	-45	-5	36	57	25
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	76%	97%	71%	114%	140%	95%	109%	81%

ARTEMISMED shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	67.17%	67.17%	66.53%	66.53%	58.38%	58.39%	58.39%	58.39%
FIIs	0.65%	0.31%	0.24%	0.37%	12.47%	12.19%	12.28%	12.45%
DIIs	4.51%	5.04%	4.76%	4.27%	2.91%	2.89%	2.40%	1.91%
Government	7.09%	7.09%	7.02%	7.02%	6.16%	6.16%	6.16%	6.16%
Public	20.59%	20.39%	21.45%	21.81%	20.07%	20.37%	20.76%	21.07%
No. of Shareholders	27,004	28,397	31,614	33,559	31,602	32,044	36,335	44,260

ARTEMISMED key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	52	50	48	47	43	36	37	38
Inventory Days	—	—	—	—	—	—	—	—
Days Payable	—	—	—	—	—	—	—	—
Cash Conversion Cycle	52	50	48	47	43	36	37	38
Working Capital Days	-51	-36	-36	-25	-45	-29	-31	-19
ROCE %	14%	11%	4%	10%	11%	14%	15%	15%

ARTEMISMEDUpdated 18 Oct 2026, 16:30

Artemis Med Service Ltd

ARTEMISMEDUpdated 18 Oct 2026, 16:30

Market Cap

₹4,850Cr.

Current Price

₹306

High / Low

₹379/203

Stock P/E

42.0

ROE11.9%

ROCE14.5%

Book Value₹59.3

Face Value₹1.00

Dividend Yield0.15%

About

Artemis Medicare Services Ltd (AMSL) was incorporated in 2004, operates a 541-bedded multi-specialty tertiary care hospital in Gurgaon.[1][2]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	201	6	174	1	9	13	26	10	0.73
Sep 2023	217	7	184	2	9	19	27	14	1.01
Dec 2023	210	8	179	2	10	16	29	12	0.85
Mar 2024	217	8	181	2	10	19	28	14	1.02
Jun 2024	217	8	181	4	10	22	24	17	1.24
Sep 2024	235	8	193	8	11	31	27	23	1.64
Dec 2024	227	8	190	9	11	27	23	21	1.51
Mar 2025	235	8	199	12	11	29	20	23	1.69
Jun 2025	250	7	209	7	11	30	29	21	1.54
Sep 2025	270	7	220	8	11	40	25	30	2.16
Dec 2025	267	7	223	4	12	30	24	23	1.42
Mar 2026	274	6	224	8	12	39	25	30	1.87
Jun 2026	282	6	227	5	12	42	26	31	1.96

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	368	12	325	3	12	21	12	19	0.88
Mar 2016	402	9	359	5	12	27	21	22	1.03
Mar 2017	459	9	406	4	15	32	16	27	1.29
Mar 2018	503	9	442	3	18	35	24	27	1.27
Mar 2019	547	11	480	2	20	37	44	21	0.98
Mar 2020	563	13	501	4	22	32	36	20	1.54
Mar 2021	402	12	367	7	21	9	20	7	0.54
Mar 2022	545	11	477	3	21	39	16	33	2.46
Mar 2023	714	19	620	7	29	53	25	40	2.96
Mar 2024	845	30	717	7	38	68	28	49	3.62
Mar 2025	913	30	763	33	43	109	24	83	6.07
Mar 2026	1060	27	875	27	46	139	25	103	6.53
TTM	1093	26	893	25	48	151	—	113	7.41

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	58.39%
FIIs	12.45%
DIIs	1.91%
Government	6.16%
Public	21.07%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Government	Public
Dec 2023	68.03%	0.11%	1.96%	7.18%	22.72%
Mar 2024	68.03%	0.1%	2.61%	7.18%	22.08%
Jun 2024	67.51%	0.16%	3.45%	7.12%	21.76%
Sep 2024	67.17%	0.21%	3.6%	7.09%	21.93%
Dec 2024	67.17%	0.65%	4.51%	7.09%	20.59%
Mar 2025	67.17%	0.31%	5.04%	7.09%	20.39%
Jun 2025	66.53%	0.24%	4.76%	7.02%	21.45%
Sep 2025	66.53%	0.37%	4.27%	7.02%	21.81%
Dec 2025	58.38%	12.47%	2.91%	6.16%	20.07%
Mar 2026	58.39%	12.19%	2.89%	6.16%	20.37%
Jun 2026	58.39%	12.28%	2.4%	6.16%	20.76%
Sep 2026	58.39%	12.45%	1.91%	6.16%	21.07%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	21	135	85	90	331	239	0	0	91	331
Mar 2016	21	163	68	93	345	249	1	0	94	345
Mar 2017	21	183	94	124	422	283	27	0	112	422
Mar 2018	21	210	91	130	452	309	43	0	100	452
Mar 2019	0	280	114	160	555	381	49	0	124	555
Mar 2020	13	301	108	159	581	387	56	2	137	581
Mar 2021	13	308	137	130	589	372	81	4	132	589
Mar 2022	13	348	190	145	697	476	64	6	152	697
Mar 2023	13	393	268	207	882	584	95	12	192	882
Mar 2024	14	438	305	191	948	699	33	15	200	948
Mar 2025	14	828	280	221	1343	729	40	15	559	1343
Mar 2026	16	923	260	225	1424	790	33	15	585	1424

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	53	-10	-35	7
Mar 2016	20	-14	-24	-18
Mar 2017	58	-74	19	3
Mar 2018	72	-67	-10	-4
Mar 2019	41	-50	14	5
Mar 2020	56	-22	-33	2
Mar 2021	27	-34	12	6
Mar 2022	61	-106	44	-2
Mar 2023	129	-153	30	7
Mar 2024	108	-90	-26	-8
Mar 2025	150	-396	274	28
Mar 2026	129	-96	-41	-8

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	39	49	48	40	52	50	48	47	43	36	37	38
Inventory Days	26	21	19	—	—	—	—	—	—	—	—	—
Days Payable	195	189	187	—	—	—	—	—	—	—	—	—
Cash Conversion Cycle	-129	-120	-120	40	52	50	48	47	43	36	37	38
Working Capital Days	-59	-31	-44	-53	-51	-36	-36	-25	-45	-29	-31	-19
ROCE %	14%	15%	16%	15%	14%	11%	4%	10%	11%	14%	15%	15%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of ARTEMIS MED SERVICE LTD (ARTEMISMED)?

The reported market capitalisation for ARTEMIS MED SERVICE LTD (ARTEMISMED) is ₹4,850Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of ARTEMISMED?

The current price shown for ARTEMIS MED SERVICE LTD (ARTEMISMED) on Fincrux is ₹306 with a 52-week high/low of ₹379/203.

What is the P/E ratio of ARTEMIS MED SERVICE LTD (ARTEMISMED)?

The stock P/E for ARTEMIS MED SERVICE LTD (ARTEMISMED) is 42.0 on Fincrux, with ROE at 11.9% and ROCE at 14.5%.

What were ARTEMISMED latest quarterly results?

For Jun 2026, ARTEMIS MED SERVICE LTD (ARTEMISMED) reported sales ₹282 Cr and net profit ₹31 Cr (figures in ₹ crore unless noted).

What are ARTEMISMED annual sales and net profit?

For TTM, ARTEMIS MED SERVICE LTD (ARTEMISMED) shows sales of ₹1,093 Cr and net profit of ₹113 Cr on the Fincrux profit & loss statement.

Who owns ARTEMIS MED SERVICE LTD (ARTEMISMED)?

Latest shareholding for ARTEMIS MED SERVICE LTD (ARTEMISMED) on Fincrux: Promoters 58.39% (Sep 2026), FIIs 12.45% (Sep 2026), DIIs 1.91% (Sep 2026), Government 6.16% (Sep 2026), Public 21.07% (Sep 2026).

Where can I find ARTEMIS MED SERVICE LTD (ARTEMISMED) financials?

ARTEMIS MED SERVICE LTD (ARTEMISMED) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show ARTEMISMED balance sheet and cash flow?

Yes. The ARTEMIS MED SERVICE LTD (ARTEMISMED) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 16:30